<?xml-stylesheet type='text/xsl' href='ctgovTransform.xsl'?>
<CT.GOV_Trial requestNumber="533">
  <stage>Registered</stage>
  <submitdate>11/02/2005</submitdate>
  <approvaldate>11/02/2005</approvaldate>
  <nctid>NCT00103597</nctid>
  <trial_identification>
    <studytitle>Efficacy of Therapeutic Interventions for Orthostatic Hypotension in Parkinson's Disease and Multiple System Atrophy</studytitle>
    <scientifictitle>Efficacy of Therapeutic Interventions for Orthostatic Hypotension in Parkinson's Disease and Multiple System Atrophy</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>2004/135</secondaryid>
    <secondaryid>2004/135</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Parkinson's Disease</healthcondition>
    <healthcondition>Multiple System Atrophy</healthcondition>
    <healthcondition>Orthostatic Hypotension</healthcondition>
    <conditioncode>
      <conditioncode1>Neurological</conditioncode1>
      <conditioncode2>Parkinson's disease</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Other</conditioncode1>
      <conditioncode2>Research that is not of generic health relevance and not applicable to specific health categories listed above</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Cardiovascular </conditioncode1>
      <conditioncode2>Diseases of the vasculature and circulation including the lymphatic system</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Neurological</conditioncode1>
      <conditioncode2>Other neurological disorders</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Neurological</conditioncode1>
      <conditioncode2>Neurodegenerative diseases</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Treatment: drugs - Fludrocortisone
Treatment: drugs - Domperidone
Behaviour - Conservative Measures for Orthostatic Hypotension

Treatment: drugs: Fludrocortisone


Treatment: drugs: Domperidone


Behaviour: Conservative Measures for Orthostatic Hypotension


</interventions>
    <comparator />
    <control />
    <interventioncode>Treatment: drugs</interventioncode>
    <interventioncode>Behaviour</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Efficacy of conservative treatment, domperidone, and fludrocortisone for patient's subjective symptoms of orthostatic hypotension, and on objective autonomic testing</outcome>
      <timepoint />
    </primaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>-  Patients residing in Queensland Australia

          -  Age 40-95

          -  Parkinson's Disease or MSA diagnosed by a neurologist

          -  Symptoms of orthostatic hypotension, as defined by 2 validated questionnaires</inclusivecriteria>
    <inclusiveminage>40</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>95</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>-  Patients with acute cardiomyopathy or cardiac condition

          -  Patients unable to give consent

          -  Patients not stable on their Parkinsonian medications

          -  Patients with another cause for autonomic neuropathy</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment>Crossover</assignment>
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 1</phase>
    <anticipatedstartdate />
    <actualstartdate>1/01/2005</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize />
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <anticipatedlastvisitdate />
    <actuallastvisitdate />
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>QLD</recruitmentstate>
    <hospital>Royal Brisbane and Women's Hospital - Brisbane</hospital>
    <postcode>4029 - Brisbane</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Other</primarysponsortype>
    <primarysponsorname>Royal Brisbane and Women's Hospital</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
  </sponsorship>
  <ethicsAndSummary>
    <summary>Patients with Parkinson's Disease or Multiple System Atrophy (MSA), and symptoms of
      orthostatic hypotension, are eligible for the study. Each patient will have three weeks of
      conservative therapy, three weeks of therapy with fludrocortisone, and three weeks of therapy
      with domperidone. Autonomic testing, a symptom questionnaire, bedside blood pressure testing,
      and Unified Parkinson Disease Rating Scale (UPDRS) will be performed after each intervention.</summary>
    <trialwebsite>https://clinicaltrials.gov/show/NCT00103597</trialwebsite>
    <publication />
    <ethicsreview />
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Kerrie Schoffer, MBBS</name>
      <address>Movement Disorders Fellow</address>
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Public Queries</type>
    </contact>
  </contacts>
</CT.GOV_Trial>